Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
174
-
Total 13F shares, excl. options
-
74,270,018
-
Shares change
-
+888,653
-
Total reported value, excl. options
-
$2,763,598,375
-
Value change
-
+$31,311,987
-
Put/Call ratio
-
85%
-
Number of buys
-
84
-
Number of sells
-
-69
-
Price
-
$37.21
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2021
201 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2021.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 174 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 74,270,018 shares
of 80,437,135 outstanding shares and own 92.33% of the company stock.
Largest 10 shareholders include FMR LLC (10,590,731 shares), WELLINGTON MANAGEMENT GROUP LLP (8,766,827 shares), VANGUARD GROUP INC (6,757,974 shares), BlackRock Inc. (6,502,733 shares), RTW INVESTMENTS, LP (5,293,966 shares), FRANKLIN RESOURCES INC (4,813,057 shares), JANUS HENDERSON GROUP PLC (3,575,187 shares), STATE STREET CORP (2,648,621 shares), ARMISTICE CAPITAL, LLC (2,596,000 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (2,105,060 shares).
This table shows the top 174 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.